A Focus on Protein Glycosylation in Lactobacillus
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Genomics of Helicobacter Species 91
Genomics of Helicobacter Species 91 6 Genomics of Helicobacter Species Zhongming Ge and David B. Schauer Summary Helicobacter pylori was the first bacterial species to have the genome of two independent strains completely sequenced. Infection with this pathogen, which may be the most frequent bacterial infec- tion of humanity, causes peptic ulcer disease and gastric cancer. Other Helicobacter species are emerging as causes of infection, inflammation, and cancer in the intestine, liver, and biliary tract, although the true prevalence of these enterohepatic Helicobacter species in humans is not yet known. The murine pathogen Helicobacter hepaticus was the first enterohepatic Helicobacter species to have its genome completely sequenced. Here, we consider functional genomics of the genus Helico- bacter, the comparative genomics of the genus Helicobacter, and the related genera Campylobacter and Wolinella. Key Words: Cytotoxin-associated gene; H-Proteobacteria; gastric cancer; genomic evolution; genomic island; hepatobiliary; peptic ulcer disease; type IV secretion system. 1. Introduction The genus Helicobacter belongs to the family Helicobacteriaceae, order Campylo- bacterales, and class H-Proteobacteria, which is also known as the H subdivision of the phylum Proteobacteria. The H-Proteobacteria comprise of a relatively small and recently recognized line of descent within this extremely large and phenotypically diverse phy- lum. Other genera that colonize and/or infect humans and animals include Campylobac- ter, Arcobacter, and Wolinella. These organisms are all microaerophilic, chemoorgano- trophic, nonsaccharolytic, spiral shaped or curved, and motile with a corkscrew-like motion by means of polar flagella. Increasingly, free living H-Proteobacteria are being recognized in a wide range of environmental niches, including seawater, marine sedi- ments, deep-sea hydrothermal vents, and even as symbionts of shrimp and tubeworms in these environments. -
R Graphics Output
883 | Desulfovibrio vulgaris | DvMF_2825 298701 | Desulfovibrio | DA2_3337 1121434 | Halodesulfovibrio aestuarii | AULY01000007_gene1045 207559 | Desulfovibrio alaskensis | Dde_0991 935942 | Desulfonatronum lacustre | KI912608_gene2193 159290 | Desulfonatronum | JPIK01000018_gene1259 1121448 | Desulfovibrio gigas | DGI_0655 1121445 | Desulfovibrio desulfuricans | ATUZ01000018_gene2316 525146 | Desulfovibrio desulfuricans | Ddes_0159 665942 | Desulfovibrio | HMPREF1022_02168 457398 | Desulfovibrio | HMPREF0326_00453 363253 | Lawsonia intracellularis | LI0397 882 | Desulfovibrio vulgaris | DVU_0784 1121413 | Desulfonatronovibrio hydrogenovorans | JMKT01000008_gene1463 555779 | Desulfonatronospira thiodismutans | Dthio_PD0935 690850 | Desulfovibrio africanus | Desaf_1578 643562 | Pseudodesulfovibrio aespoeensis | Daes_3115 1322246 | Pseudodesulfovibrio piezophilus | BN4_12523 641491 | Desulfovibrio desulfuricans | DND132_2573 1121440 | Desulfovibrio aminophilus | AUMA01000002_gene2198 1121456 | Desulfovibrio longus | ATVA01000018_gene290 526222 | Desulfovibrio salexigens | Desal_3460 1121451 | Desulfovibrio hydrothermalis | DESAM_21057 1121447 | Desulfovibrio frigidus | JONL01000008_gene3531 1121441 | Desulfovibrio bastinii | AUCX01000006_gene918 1121439 | Desulfovibrio alkalitolerans | dsat_0220 941449 | Desulfovibrio | dsx2_0067 1307759 | Desulfovibrio | JOMJ01000003_gene2163 1121406 | Desulfocurvus vexinensis | JAEX01000012_gene687 1304872 | Desulfovibrio magneticus | JAGC01000003_gene2904 573370 | Desulfovibrio magneticus | DMR_04750 -
9 Methods to Identify and Enumerate Frank and Opportunistic Bacterial Pathogens in Water and Biofilms
9 Methods to identify and enumerate frank and opportunistic bacterial pathogens in water and biofilms N.J. Ashbolt 9.1 INTRODUCTION The vast range of heterotrophic plate count (HPC)-detected bacteria are not considered to be frank or opportunistic pathogens, as discussed elsewhere in this book (chapters 4–7) and in previous reviews (Nichols et al. 1995; LeChevallier et al. 1999; Velazquez and Feirtag 1999; Szewzyk et al. 2000). The purpose of this chapter, however, is to highlight important methodological issues when considering “traditional” and emerging procedures for detecting bacterial pathogens in both water and biofilms, rather than giving specific methods for many pathogens. 2003 World Health Organization (WHO). Heterotrophic Plate Counts and Drinking-water Safety. Edited by J. Bartram, J. Cotruvo, M. Exner, C. Fricker, A. Glasmacher. Published by IWA Publishing, London, UK. ISBN: 1 84339 025 6. Methods to identify and enumerate bacterial pathogens in water 147 The focus of this book is on heterotrophic bacteria; nevertheless, many of the methods discussed can also be directed to other (viral and protozoan) frank and opportunistic pathogens. Furthermore, a number of heterotrophs are thought to cause disease via the expression of virulence factors (Nichols et al. 1995), such as the emerging bacterial superantigens (McCormick et al. 2001). Hence, pathogen detection is not necessarily one based on particular species, but may take the approach of identifying virulence gene(s), preferably by their active expression (possibly including a range of different genera of bacteria; see virulence factors in Table 9.1). As a consequence, many species contain pathogenic and non-pathogenic strains, so ways to “fingerprint” strains of importance (from the environment and human cases) are also discussed in detail. -
Co-Evolution of Epibiotic Bacteria Associated with the Novel
Identity of epibiotic bacteria on symbiontid euglenozoans in O2-depleted marine sediments: evidence for symbiont and host co-evolution 1*Edgcomb, V.P., 2Breglia, S.A., 2Yubuki, N., 3Beaudoin, D., 4Patterson, D.J., 2Leander, B.S. and 1Bernhard, J.M. 1Woods Hole Oceanographic Institution, Geology and Geophysics Department, Woods Hole, MA 02543, USA 2Canadian Institute for Advanced Research, Program in Integrated Microbial Biodiversity, Departments of Botany and Zoology, University of British Columbia, 6270 University Boulevard, Vancouver, BC V6T 1Z4, Canada 3Woods Hole Oceanographic Institution, Biology Department, Woods Hole, MA 02543, USA 4Marine Biological Laboratory, Biodiversity Informatics, Marine Biological Laboratory, Woods Hole, Massachusetts 02543, USA. Running title: Identity of epibionts on symbiontid euglenozoans Keywords: Symbiontida, epibionts, epsilon-proteobacteria, Calkinsia, Bihospites, co-evolution, sulfide Subject categories: 1) Microbe-microbe and microbe-host interactions 2) Evolutionary genetics *Corresponding author Abstract A distinct subgroup of euglenozoans, referred to as the “Symbiontida,” has been described from oxygen-depleted and sulfidic marine environments. By definition, all members of this group carry epibionts that are intimately associated with underlying mitochondrion-derived organelles beneath the surface of the hosts. We have used molecular phylogenetic and ultrastructural evidence to identify the rod-shaped epibionts of two members of this group, Calkinsia aureus and Bihospites bacati, hand-picked from sediments from two separate oxygen-depleted, sulfidic environments. We identify their epibionts as closely related sulfur or sulfide oxidizing members of the Epsilon proteobacteria. The Epsilon proteobacteria generally play a significant role in deep-sea habitats as primary colonizers, primary producers, and/or in symbiotic associations. The epibionts likely fulfill a role in detoxifying the immediate surrounding environment for these two different hosts. -
Standard Operating Procedure◄
►Standard Operating Procedure◄ Section: Laboratory Version: FINAL Initials: AD Title: 2.0 Testing Algorithm Revision Date: 20 Oct 2011 1. Definitions 1.1 SOP: Standard Operating Procedure 1.2 CRF: Case Report Form 2. Purpose / Background 2.1. The purpose of this SOP is to provide guidance for the processing, testing and storage of all PERCH study specimens. 3. Scope / Applicability 3.1. This SOP applies to all laboratory personnel involved in the processing of laboratory specimens. 4. Prerequisites / Supplies Needed 4.1. See test specific SOPs for supplies needed. 5. Roles / Responsibilities [Site specific, as needed] 6. Procedural Steps 6.1 Accepting/Rejecting Specimens: Staff who receive specimens in the laboratory are responsible, to the best of their ability, for ensuring that specimens have been stored and transported under the conditions specified in Appendix 1, Specimen Transport and Storage Conditions. Specimens will only be rejected for processing for the following reasons: (a) specimen is unlabeled (b) specimen ID does not match the requisition form (c) blood is hemolyzed, or anticoagulated specimens contain clots (d) specimen container is leaking. 6.2 Process all study specimens according to the flow charts and specimen preparation tables below. Any departure from the flow charts listed below (e.g. instances of insufficient volume) should be documented as part of the laboratory’s quality management process. For specific processing instructions, please refer to the relevant specimen processing SOP. SOP ID# 2.0 Testing Algorithm version : FINAL Page 2 of 30 *NB As an alternative, all EDTA blood from cases 6.1a can be collected into one tube. -
Whole-Genome Sequencing and Bioinformatics As Pertinent Tools To
Whole-Genome Sequencing and Bioinformatics as Pertinent Tools to Support Helicobacteracae Taxonomy, Based on Three Strains Suspected to Belong to Novel Helicobacter Species Elvire Berthenet, Lucie Bénéjat, Armelle Ménard, Christine Varon, Sabrina Lacomme, Etienne Gontier, Josette Raymond, Ouahiba Boussaba, Olivier Toulza, Astrid Ducournau, et al. To cite this version: Elvire Berthenet, Lucie Bénéjat, Armelle Ménard, Christine Varon, Sabrina Lacomme, et al.. Whole- Genome Sequencing and Bioinformatics as Pertinent Tools to Support Helicobacteracae Taxonomy, Based on Three Strains Suspected to Belong to Novel Helicobacter Species. Frontiers in Microbiology, Frontiers Media, 2019, 10, pp.2820. 10.3389/fmicb.2019.02820. inserm-03004847 HAL Id: inserm-03004847 https://www.hal.inserm.fr/inserm-03004847 Submitted on 13 Nov 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. fmicb-10-02820 December 5, 2019 Time: 16:13 # 1 ORIGINAL RESEARCH published: 06 December 2019 doi: 10.3389/fmicb.2019.02820 Whole-Genome Sequencing and Bioinformatics as Pertinent Tools -
Leading Article Non-Pylori Helicobacter Species in Humans
Gut 2001;49:601–606 601 Gut: first published as 10.1136/gut.49.5.601 on 1 November 2001. Downloaded from Leading article Non-pylori helicobacter species in humans Introduction Another bacterium, Helicobacter felis, which is morphologi- The discovery of Helicobacter pylori in 1982 increased cally similar to H heilmannii by light microscopy, has also interest in the range of other spiral bacteria that had been been noted in three cases.7–9 Its identification is based on seen not only in the stomach but also in the lower bowel of the presence of periplasmic fibres which are only visible by many animal species.12The power of technologies such as electron microscopy. H felis has been used extensively in the polymerase chain reaction with genus specific primers mouse models of H pylori infection.10 revealed that many of these bacteria belong to the genus Since the first report in 1987, over 500 cases of human Helicobacter. These non-pylori helicobacters are increas- gastric infection with H heilmannii have appeared in the lit- ingly being found in human clinical specimens. The erature.11 The prevalence of this infection is low, ranging purpose of this article is to introduce these microorganisms from ∼ 0.5 % in developed countries5 7 12–15 to 1.2–6.2% in to the clinician, put them in an ecological perspective, and Eastern European and Asian countries.16–19 to reflect on their likely importance as human pathogens. H heilmannii, like H pylori, is associated with a range of upper gastrointestinal symptoms, histologic, and endo- Gastric bacteria scopic findings. -
Bibliography
Bibliography Aa, K. and R.A. Olsen. 1996. The use of various substrates and substrate caulis Poindexter by a polyphasic analysis. Int. J. Syst. Evol. Microbiol. concentrations by a Hyphomicrobium sp. isolated from soil: effect on 51: 27–34. growth rate and growth yield. Microb. Ecol. 31: 67–76. Abram, D., J. Castro e Melo and D. Chou. 1974. Penetration of Bdellovibrio Aalen, R.B. and W.B. Gundersen. 1985. Polypeptides encoded by cryptic bacteriovorus into host cells. J. Bacteriol. 118: 663–680. plasmids from Neisseria gonorrhoeae. Plasmid 14: 209–216. Abramochkina, F.N., L.V. Bezrukova, A.V. Koshelev, V.F. Gal’chenko and Aamand, J., T. Ahl and E. Spieck. 1996. Monoclonal antibodies recog- M.V. Ivanov. 1987. Microbial methane oxidation in a fresh-water res- nizing nitrite oxidoreductase of Nitrobacter hamburgensis, N. winograd- ervoir. Mikrobiologiya 56: 464–471. skyi, and N. vulgaris. Appl. Environ. Microbiol. 62: 2352–2355. Achenbach, L.A., U. Michaelidou, R.A. Bruce, J. Fryman and J.D. Coates. Aarestrup, F.M., E.M. Nielsen, M. Madsen and J. Engberg. 1997. Anti- 2001. Dechloromonas agitata gen. nov., sp. nov. and Dechlorosoma suillum microbial susceptibility patterns of thermophilic Campylobacter spp. gen. nov., sp. nov., two novel environmentally dominant from humans, pigs, cattle, and broilers in Denmark. Antimicrob. (per)chlorate-reducing bacteria and their phylogenetic position. Int. Agents Chemother. 41: 2244–2250. J. Syst. Evol. Microbiol. 51: 527–533. Abadie, M. 1967. Formations intracytoplasmique du type “me´some” chez Achouak, W., R. Christen, M. Barakat, M.H. Martel and T. Heulin. 1999. Chondromyces crocatus Berkeley et Curtis. -
Comparative Genomics of Helicobacter Pylori
Schott et al. BMC Genomics 2011, 12:534 http://www.biomedcentral.com/1471-2164/12/534 RESEARCHARTICLE Open Access Comparative Genomics of Helicobacter pylori and the human-derived Helicobacter bizzozeronii CIII-1 strain reveal the molecular basis of the zoonotic nature of non-pylori gastric Helicobacter infections in humans Thomas Schott, Pradeep K Kondadi, Marja-Liisa Hänninen and Mirko Rossi* Abstract Background: The canine Gram-negative Helicobacter bizzozeronii is one of seven species in Helicobacter heilmannii sensu lato that are detected in 0.17-2.3% of the gastric biopsies of human patients with gastric symptoms. At the present, H. bizzozeronii is the only non-pylori gastric Helicobacter sp. cultivated from human patients and is therefore a good alternative model of human gastric Helicobacter disease. We recently sequenced the genome of the H. bizzozeronii human strain CIII-1, isolated in 2008 from a 47-year old Finnish woman suffering from severe dyspeptic symptoms. In this study, we performed a detailed comparative genome analysis with H. pylori, providing new insights into non-pylori Helicobacter infections and the mechanisms of transmission between the primary animal host and humans. Results: H. bizzozeronii possesses all the genes necessary for its specialised life in the stomach. However, H. bizzozeronii differs from H. pylori by having a wider metabolic flexibility in terms of its energy sources and electron transport chain. Moreover, H. bizzozeronii harbours a higher number of methyl-accepting chemotaxis proteins, allowing it to respond to a wider spectrum of environmental signals. In this study, H. bizzozeronii has been shown to have high level of genome plasticity. -
Helicobacter Spp
DOI:10.1111/j.1477-2574.2009.00148.x HPB ORIGINAL ARTICLE Identification of Helicobacter spp. in bile and gallbladder tissue of patients with symptomatic gallbladder disease M. Shirin Sabbaghian1, Jeffrey Ranaudo1, Lin Zeng1, Alexandra P. Alongi1, Guillermo Perez-Perez2 & Peter Shamamian3 1Department of Surgery, New York University Langone Medical Center, New York, NY and 2Department of Medicine, New York University School of Medicine, New York, NY and 3Department of Surgery, Ralph H. Johnson Veterans Affairs Medical Center, Charleston and the Medical University of South Carolina, Charleston, SC, USA Abstracthpb_148 129..133 Background: This experimental study was designed to determine if Helicobacter spp. contribute to benign gallbladder disease using polymerase chain reaction (PCR) methods. Methods: Patients with benign gallbladder disease scheduled for elective cholecystectomy at New York University Langone Medical Center were recruited from February to May 2008. Bile, gallbladder tissue and gallstones were collected. DNA was isolated from these specimens and amplified via PCR using C97F and C98R primers specific for Helicobacter spp. Appropriate positive and negative controls were used. Products were analysed with agarose gel electrophoresis, sequenced and results aligned using SEQUENCHER. Plasma was collected for detection of anti-Helicobacter pylori antibodies via enzyme-linked immunosorbent assay. Results: Of 36 patients, 12 patients' bile and/or tissue were positive for Helicobacter spp. by PCR. Species were most homologous with H. pylori, although other Helicobacter spp. were suggested. Six of 12 patients demonstrated anti-Helicobacter antibodies in plasma, suggesting that the remaining six might have demonstrated other species besides H. pylori. Four of six plasma samples with anti-Helicobacter antibodies were anti-CagA (cytotoxin associated gene) negative. -
Supplementary Figure
Supplementary Figure Proteomic Examination for Gluconeogenesis Pathway-Shift during Polyhydroxyalkanoate Formation in Cupriavidus necator Grown on Glycerol Nuttapol Tanadchangsaeng 1,* and Sittiruk Roytrakul 2 1 College of Biomedical Engineering, Rangsit University, 52/347 Phahonyothin Road, Lak-Hok, Pathumthani 12000 Thailand; [email protected] 2 Proteomics Research Laboratory, National Center for Genetic Engineering and Biotechnology (BIOTEC), 113 Thailand Science Park, Khlong Luang, Pathumthani 12120 Thailand; [email protected] * Correspondence: [email protected]; Tel.: +66-(0)2-997-2200 ext. 1428, Fax: +66-(0)2-997-2200 ext. 1408 1 Supplementary Figure FIGURE CAPTIONS Figure S1 NMR spectra of culture medium showed glucose peak during PHA synthesis. Figure S2 Cluster of proteins using the multiple array viewer (MEV) program using the KMS data analysis model. The above is for PHA synthesis correlation, while the below is for the glucose synthesis correlation. 2 Supplementary Figure 60 h Glucose compound peaks D2O peak 42 h 35 h 20 h Figure S1 Tanadchangsaeng et al. 3 Figure S2 Tanadchangsaeng et al. 4 Table S1: The protein analysis inside Cupriavidus necator cells discovered 1361 proteins with different expressions. Number Protein name Accession numberID Score Peptide 20H 35H 42H 60H 35H/20H 42H/20H 60H/20H 1 cytochrome b/b6-like protein [Sphingopyxis alaskensis RB2256] gi|103486830 0.589999974 SAATA 17.2005 16.3885 16.00849 16.45532 0.95279207 0.930699108 0.956676841 2 glucose-6-phosphate isomerase [Pseudomonas entomophila -
Protein Glycosylation in Bacteria: Sweeter Than Ever
REVIEWS Protein glycosylation in bacteria: sweeter than ever Harald Nothaft and Christine M. Szymanski Abstract | Investigations into bacterial protein glycosylation continue to progress rapidly. It is now established that bacteria possess both N-linked and O-linked glycosylation pathways that display many commonalities with their eukaryotic and archaeal counterparts as well as some unexpected variations. In bacteria, protein glycosylation is not restricted to pathogens but also exists in commensal organisms such as certain Bacteroides species, and both the N-linked and O-linked glycosylation pathways can modify multiple proteins. Improving our understanding of the intricacies of bacterial protein glycosylation systems should lead to new opportunities to manipulate these pathways in order to engineer glycoproteins with potential value as novel vaccines. S-layer Glycosylation is the most abundant polypeptide in the past 5 years (for a review of earlier work, see Two-dimensional array of chain modification in nature. Glycans can be cova- REF. 14). Our understanding of bacterial flagellin- and protein or glycoprotein lently attached to the amide nitrogen of Asn residues pilin-specific O-glycosylation systems has also been subunits, each with molecular (N-glycosylation), to the hydroxyl oxygen of, typically, growing, and general O-glycosylation pathways have masses ranging from 40 to Ser or Thr residues (O-glycosylation), and, in rare cases, been identified recently as a result of the development of 200 kDa, that are common (BOX 1) constituents of bacterial cell to the indole C2 carbon of Trp through a C–C linkage new and more sensitive detection methods . These 1 walls. (C-mannosylation , which will not be discussed further).